Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 434

Similar articles for PubMed (Select 11134202)

1.

Measuring the incremental cost of clinical cancer research.

Goldman DP, Schoenbaum ML, Potosky AL, Weeks JC, Berry SH, Escarce JJ, Weidmer BA, Kilgore ML, Wagle N, Adams JL, Figlin RA, Lewis JH, Cohen J, Kaplan R, McCabe M.

J Clin Oncol. 2001 Jan 1;19(1):105-10.

PMID:
11134202
2.

Evaluating the financial impact of clinical trials in oncology: results from a pilot study from the Association of American Cancer Institutes/Northwestern University clinical trials costs and charges project.

Bennett CL, Stinson TJ, Vogel V, Robertson L, Leedy D, O'Brien P, Hobbs J, Sutton T, Ruckdeschel JC, Chirikos TN, Weiner RS, Ramsey MM, Wicha MS.

J Clin Oncol. 2000 Aug;18(15):2805-10.

PMID:
10920127
3.

Incremental costs of enrolling cancer patients in clinical trials: a population-based study.

Wagner JL, Alberts SR, Sloan JA, Cha S, Killian J, O'Connell MJ, Van Grevenhof P, Lindman J, Chute CG.

J Natl Cancer Inst. 1999 May 19;91(10):847-53. Erratum in: J Natl Cancer Inst 2000 Jan 19;92(2):164-5.

4.

Cancer trial enrollment after state-mandated reimbursement.

Gross CP, Murthy V, Li Y, Kaluzny AD, Krumholz HM.

J Natl Cancer Inst. 2004 Jul 21;96(14):1063-9.

5.

Clinical trials: are they a good buy?

Bennett CL, Adams JR, Knox KS, Kelahan AM, Silver SM, Bailes JS.

J Clin Oncol. 2001 Dec 1;19(23):4330-9.

PMID:
11731516
6.

Incremental treatment costs in national cancer institute-sponsored clinical trials.

Goldman DP, Berry SH, McCabe MS, Kilgore ML, Potosky AL, Schoenbaum ML, Schonlau M, Weeks JC, Kaplan R, Escarce JJ.

JAMA. 2003 Jun 11;289(22):2970-7.

PMID:
12799405
7.

An estimate of the cost of conducting phase II trials in lung cancer.

Evans WK, Dahrouge S, Stapleton J, Quinn C, Pollock D, Waterfield B, Lister D, Hansel F, Smith A.

Lung Cancer. 2000 May;28(2):85-95.

PMID:
10717326
8.

Reimbursement issues facing patients, providers, and payers.

Antman K.

Cancer. 1993 Nov 1;72(9 Suppl):2842-5.

PMID:
8402516
9.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
10.
11.
12.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
13.

Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Higashida RT, Furlan AJ, Roberts H, Tomsick T, Connors B, Barr J, Dillon W, Warach S, Broderick J, Tilley B, Sacks D; Technology Assessment Committee of the American Society of Interventional and Therapeutic Neuroradiology; Technology Assessment Committee of the Society of Interventional Radiology.

Stroke. 2003 Aug;34(8):e109-37. Epub 2003 Jul 17. Erratum in: Stroke. 2003 Nov;34(11):2774.

14.

Free-riding and the prisoner's dilemma: problems in funding economic analyses of phase III cancer clinical trials.

Bennett CL, Smith TJ, George SL, Hillner BE, Fleishman S, Niell HB.

J Clin Oncol. 1995 Sep;13(9):2457-63. Review.

PMID:
7545222
15.

Third-party payers and the cost of biomedical research.

Iltis AS.

Kennedy Inst Ethics J. 2005 Jun;15(2):135-60.

PMID:
16149205
16.

Economic analyses of phase III cooperative cancer group clinical trials: are they feasible?

Bennett CL, Golub R, Waters TM, Tallman MS, Rowe JM.

Cancer Invest. 1997;15(3):227-36.

PMID:
9171857
17.

Treatment costs associated with interventional cancer clinical trials conducted at a single UK institution over 2 years (2009-2010).

Liniker E, Harrison M, Weaver JM, Agrawal N, Chhabra A, Kingshott V, Bailey S, Eisen TG, Corrie PG.

Br J Cancer. 2013 Oct 15;109(8):2051-7. doi: 10.1038/bjc.2013.495. Epub 2013 Sep 24.

18.
19.

Factors influencing enrollment in clinical trials for cancer treatment.

Klabunde CN, Springer BC, Butler B, White MS, Atkins J.

South Med J. 1999 Dec;92(12):1189-93.

PMID:
10624912
20.

American Society of Clinical Oncology guidance statement: the cost of cancer care.

Meropol NJ, Schrag D, Smith TJ, Mulvey TM, Langdon RM Jr, Blum D, Ubel PA, Schnipper LE; American Society of Clinical Oncology.

J Clin Oncol. 2009 Aug 10;27(23):3868-74. doi: 10.1200/JCO.2009.23.1183. Epub 2009 Jul 6.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk